<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03969615</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0371</org_study_id>
    <nct_id>NCT03969615</nct_id>
  </id_info>
  <brief_title>SuperNO2VA™ and General Anesthesia Postoperative Care</brief_title>
  <official_title>SuperNO2VA™ and General Anesthesia Postoperative Care: Comparing the Incidence, Severity, and Duration of Postoperative Oxygen Desaturation Between SuperNO2VA™ and Standard of Care, a RCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vyaire Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vyaire Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to randomly and prospectively evaluate the differences in
      outcomes between the control group (closed full facemask immediate post-extubation with
      standard oxygenating device used post-operatively in PACU) and the SuperNO2VA™ group
      (SuperNO2VA™ immediate post-extubation and post-operatively in PACU)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Anticipated">October 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hypoxemia</measure>
    <time_frame>Within 90 minutes of extubation between the two study groups.</time_frame>
    <description>Compare the incidence, severity, and duration of postoperative oxygen desaturation (oxygen saturation below 90% for greater than 1 consecutive minute)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Airway maneuvers</measure>
    <time_frame>Within 90 minutes of extubation</time_frame>
    <description>Compare the number of airway interventions including chin up and/or jaw thrust, oral and/or nasal airway insertion, mask ventilation, intubation with ETT or SGA insertion performed by anesthesia providers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post op respiratory complications</measure>
    <time_frame>Within 90 minutes of extubation</time_frame>
    <description>Compare the incidence of respiratory complications between the two groups (shortness of breath, respiratory rate &gt; 20 breaths per minute, accessory muscle use, difficulty breathing/swallowing/speaking)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of PACU stay</measure>
    <time_frame>Within 24 hours of surgery</time_frame>
    <description>Compare the length of stay (time ready for discharge) in the recovery period between the control group and the SuperNO2VA™ group.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hypoxemia</condition>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Supplemental oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5lpm of supplemental oxygen via a nasal cannula or face mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SuperNO2VA nasal positive airway pressure device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention arm will receive the SuperNO2VA nasal positive pressure device at 10lpm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SuperNO2VA nasal positive airway pressure devic</intervention_name>
    <description>SuperNO2VA nasal positive airway pressure device utilizes supplemental oxygen and an adjustable pressure limiting valve to maintain upper airway latency</description>
    <arm_group_label>SuperNO2VA nasal positive airway pressure device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Supplemental oxygen</intervention_name>
    <description>5lpm of supplemental oxygen</description>
    <arm_group_label>Supplemental oxygen</arm_group_label>
    <other_name>nasal cannula</other_name>
    <other_name>face mask</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years of age or older

          2. Patients scheduled for general anesthesia with a supraglottic device or ETT

          3. American Society of Anesthesiology (ASA) Physical Status I-IV (E)

          4. Has provided written informed consent

          5. BMI &gt; 35 kg/m2 or documented Obstructive Sleep Apnea

        Exclusion Criteria:

          1. Inability to give informed consent

          2. ASA V (E)

          3. Allergy to Propofol

          4. Any condition, in the Investigator's opinion, that would conflict or otherwise prevent
             the subject from complying with study required procedures, schedule or other study
             conduct

          5. BMI &lt; 35 kg/m2 with no documented diagnosis (known) of Obstructive Sleep Apnea

          6. Known diagnosis of moderate to severe COPD/lung disease

          7. Patients that remained intubated post-operatively

          8. Patient refusal to wear the treatment device (SuperNO2VA™, nasal cannula, or oxygen
             facemask) for the duration of the study period postoperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carin Hagberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas, MD Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carin Hagberg, MD</last_name>
    <phone>7135633511</phone>
    <email>chagberg@mdanderson.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shannon Hancher-Hodges, MD</last_name>
    <email>shancher@mdanderson.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas, MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carin Hagberg, MD</last_name>
      <phone>713-563-3511</phone>
      <email>chagberg@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Shannon Hancher-Hodges, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Sun Z, Sessler DI, Dalton JE, Devereaux PJ, Shahinyan A, Naylor AJ, Hutcherson MT, Finnegan PS, Tandon V, Darvish-Kazem S, Chugh S, Alzayer H, Kurz A. Postoperative Hypoxemia Is Common and Persistent: A Prospective Blinded Observational Study. Anesth Analg. 2015 Sep;121(3):709-15. doi: 10.1213/ANE.0000000000000836.</citation>
    <PMID>26287299</PMID>
  </results_reference>
  <results_reference>
    <citation>Simonneau G, Vivien A, Sartene R, Kunstlinger F, Samii K, Noviant Y, Duroux P. Diaphragm dysfunction induced by upper abdominal surgery. Role of postoperative pain. Am Rev Respir Dis. 1983 Nov;128(5):899-903.</citation>
    <PMID>6638679</PMID>
  </results_reference>
  <results_reference>
    <citation>Mutter TC, Chateau D, Moffatt M, Ramsey C, Roos LL, Kryger M. A matched cohort study of postoperative outcomes in obstructive sleep apnea: could preoperative diagnosis and treatment prevent complications? Anesthesiology. 2014 Oct;121(4):707-18. doi: 10.1097/ALN.0000000000000407.</citation>
    <PMID>25247853</PMID>
  </results_reference>
  <results_reference>
    <citation>Abdelsattar ZM, Hendren S, Wong SL, Campbell DA Jr, Ramachandran SK. The Impact of Untreated Obstructive Sleep Apnea on Cardiopulmonary Complications in General and Vascular Surgery: A Cohort Study. Sleep. 2015 Aug 1;38(8):1205-10. doi: 10.5665/sleep.4892.</citation>
    <PMID>25761980</PMID>
  </results_reference>
  <results_reference>
    <citation>Smith PL, Wise RA, Gold AR, Schwartz AR, Permutt S. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985). 1988 Feb;64(2):789-95.</citation>
    <PMID>3372436</PMID>
  </results_reference>
  <results_reference>
    <citation>Cabrini L, Nobile L, Plumari VP, Landoni G, Borghi G, Mucchetti M, Zangrillo A. Intraoperative prophylactic and therapeutic non-invasive ventilation: a systematic review. Br J Anaesth. 2014 Apr;112(4):638-47. doi: 10.1093/bja/aet465. Epub 2014 Jan 19. Review.</citation>
    <PMID>24444661</PMID>
  </results_reference>
  <results_reference>
    <citation>Neligan PJ, Malhotra G, Fraser M, Williams N, Greenblatt EP, Cereda M, Ochroch EA. Continuous positive airway pressure via the Boussignac system immediately after extubation improves lung function in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesthesiology. 2009 Apr;110(4):878-84. doi: 10.1097/ALN.0b013e31819b5d8c.</citation>
    <PMID>19293693</PMID>
  </results_reference>
  <results_reference>
    <citation>Jaber S, De Jong A, Castagnoli A, Futier E, Chanques G. Non-invasive ventilation after surgery. Ann Fr Anesth Reanim. 2014 Jul-Aug;33(7-8):487-91. doi: 10.1016/j.annfar.2014.07.742. Epub 2014 Aug 29. Review.</citation>
    <PMID>25168304</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 29, 2019</study_first_submitted>
  <study_first_submitted_qc>May 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>May 30, 2019</last_update_submitted>
  <last_update_submitted_qc>May 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

